![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 51, 49101-49104, December 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
,
,
From the
Molecular Neurobiology Group, Department of
Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot,
Israel, the § Division of Regulation of Macromolecular
Functions, Institute for Protein Research, Osaka University, Osaka
565-0871, Japan, and the ¶ Department of Medical
Biochemistry and Biophysics, Karolinska Institute, S-17177
Stockholm, Sweden
Received for publication, September 19, 2002, and in revised form, October 21, 2002
| |
ABSTRACT |
|---|
|
|
|---|
The p75 neurotrophin receptor has been implicated
in diverse aspects of neurotrophin signaling, but the mechanisms by
which its effects are mediated are not well understood. Here we
identify two MAGE proteins, necdin and MAGE-H1, as interactors for the intracellular domain of p75 and show that the interaction is enhanced by ligand stimulation. PC12 cells transfected with necdin or MAGE-H1 exhibit accelerated differentiation in response to nerve growth factor. Expression of these two MAGE proteins is predominantly cytoplasmic in PC12 cells, and necdin was found to be capable of
homodimerization, suggesting that it may act as a cytoplasmic adaptor
to recruit a signaling complex to p75. These findings indicate that
diverse MAGE family members can interact with the p75 receptor and
highlight type II MAGE proteins as a potential family of interactors
for signaling proteins containing type II death domains.
Neuronal responses to activation of the p75 neurotrophin receptor
range from enhanced outgrowth to increased cell death, and p75 null
mice exhibit a plethora of defects in both neuronal and non-neuronal
systems (1, 2). However, the primary interactors and signaling
mechanisms activated by p75 are not well understood (3). Although p75
belongs to the TNF receptor superfamily, its intracellular type II
death domain does not self-aggregate (4) and does not interact with the
major binding partners of type I death domains. Identification of
specific signaling partners for p75 has been frustrating, as this
particular receptor is a difficult bait in conventional yeast
two-hybrid. Nonetheless seven candidate interactors have been
reported so far for p75 (3, 5). Most of these candidate interactors
lack known catalytic domains, suggesting that they must recruit
additional binding partners to form a functional signaling complex.
There are no general sequence or functional homologies between the
described p75 interactors, and the physiological significance of most
of them remains to be established.
To identify biologically relevant interactors for p75, we used the Ras
rescue system (RRS)1 for
protein interaction trapping in yeast (6). RRS selects for protein
interactions in the membrane proximal region of the cytoplasm, and
there is no requirement for nuclear or other translocations of the
binding partners. The system thus provides an appropriate screening
method for the membrane-proximal binding of a receptor intracellular
domain with its primary interactors. Our RRS screens identified two
MAGE family proteins as novel p75 interactors and highlight type II
MAGE proteins as a potential interactor family for type II death domain proteins.
RRS Screens, cDNA Cloning, and Sequence
Analysis--
Plasmids, yeast strains, and screening protocols for RRS
were as described (6). Linker (K274RWN to
SLPL342) and death domain (T343KRE to
ESLC416) regions of p75-ICD were generated by PCR from rat
p75. Synthetic oligonucleotides were designed to encode the
nine-residue (SESTATSPV) tail domain of p75-ICD. A pADH death domain
bait was used to screen a mouse embryonic head cDNA library in
pMyr. Alignments of MAGE sequences and phylogenetic trees were
constructed using ClustalX.
Expression Analysis--
Rat tissues for Western blot analysis
were flash-frozen in liquid nitrogen, macerated to a fine powder, and
solubilized in 10 mM Tris, pH 8.0, 150 mM NaCl,
10% glycerol, 1 mM PMSF, 1 mM orthovanadate
and proteinase inhibitors (Merck) containing 1% Nonidet P-40. Extracts
were separated on SDS-PAGE, blotted, and probed with anti-necdin antibodies.
Cell Culture, Transfections, and Generation of Cell
Lines--
PC12 cells were maintained in Dulbecco's modified Eagle's
medium containing 6% fetal calf serum and 6% horse serum. For
induction of neuronal differentiation, the cells were seeded at a
density of 10-15 × 105 cells/cm2 and
differentiated for 2-4 days with NGF (5-50 ng/ml). Transient transfection of COS cells was with DEAE-dextran. Transient and stable
transfections of PC12 cells lines were carried out by electroporation with 80 µg of DNA per 107 cells in 0.4-cm cuvettes on an
ECM-300 (BTX) set to 320 V, 6-ms pulse length. Stably transfected PC12
were selected under 0.5 mg/ml Geneticin for ~4 weeks until resistant
colonies appeared.
Immunoprecipitation, Western Blots, and
Immunofluorescence--
Cells were lysed in 10 mM Tris,
pH8.0, 150 mM NaCl, 10% glycerol, 1 mM PMSF, 1 mM orthovanadate and proteinase inhibitors (Merck)
containing either 0.7% CHAPS or 1% Nonidet P-40. Lysates were spun at
10,000 × g for 5 min and then precleared with 30 µl
of a 50% suspension of protein-G-Sepharose beads (Amersham Biosciences) before incubation with primary antibody.
Immunoprecipitates were eluted with 80 µl of 1 M
guanidine HCl in 50 mM Tris, pH 8.0, before running on
SDS-PAGE. Primary antibodies for precipitation were as follows:
anti-p75 MC192 (from Alomone Laboratories), anti-p75 REX (7),
monoclonal anti-HA (from Roche Molecular Biochemicals). Antibodies and dilutions for Western blots were as follows:
anti-necdin polyclonal NC243 (8) at 1:5000, anti-necdin polyclonal MNF (9) at 1:1000, anti-HA polyclonal (Santa Cruz) at 1:200, anti-p75 polyclonal 9651 at 1:1000, anti-phospho-cdc2 polyclonal (R & D Systems) at 5 µg/ml, and anti-TrkA RTA (10) at 1:1000. Cells were
fixed for immunofluorescence microscopy for 20 min with ice-cold 3%
paraformaldehyde in PBS at room temperature, quenched in 0.1 M glycine PBS for 15 min, and permeabilized for 10 min in
PBS, 5% donkey serum, 1 mg/ml bovine serum albumin, 0.2% saponin.
Permeabilized cells were incubated with anti-HA (1:4000) for 2 h
at room temperature followed by donkey anti-rabbit
rhodamine-redX-conjugated secondary antibody (1:500, Jackson
ImmunoResearch) for 1 h at room temperature.
A mouse embryonic head RRS library was screened against three
baits comprising the death domain, the 69-residue juxtamembrane "linker," and the nine-residue C-terminal "tail" of p75. These screens yielded interacting candidates only for the death domain bait.
One of the clones encoded the C-terminal 81 amino acid residues of
necdin (11), a MAGE family member thought to act as a cell cycle
regulator. Further yeast co-transfections of necdin with the complete
panel of p75-ICD subdomains revealed that necdin interacts with both
the linker and death domain segments of p75 (Fig.
1A). The sequence homologies
between necdin and NRAGE, which was previously identified by Barker and
colleagues as a p75 interactor (12), prompted us to examine additional
family members. Unfortunately, a number of MAGE constructs (e.g. NRAGE
and MAGEL2) were found to associate with yeast plasma membrane, thus
precluding their use in the RRS system. MAGE-H1/APR-1 (13) was found to
interact robustly with the p75 death domain by RRS (data not shown).
Thus, at least three type II MAGE proteins (Fig. 1B) are
capable of interacting with p75. Tissue RNA arrays (data not shown) and
in silico profiling reveal extensive overlaps in the expression
profiles of these genes. Adult rats express robust levels of necdin
protein in the hypothalamus and in dorsal root ganglia (DRG) (Fig.
1C), whereas necdin levels during development are much
lower.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (30K):
[in a new window]
Fig. 1.
Necdin, a MAGE family protein, interacts with
p75. A, myristoylated linker and death domain
regions of p75 interact with necdin-Ras to rescue transformed yeast
grown at 36 °C, whereas no interaction is observed with the tail
domain. B, phylogenetic tree showing relationships between
human type II MAGE genes; * denotes those shown to interact with p75.
C, Western blot analysis of necdin expression in rat
tissues. 250 µg of tissue protein was loaded in each lane, and the
blot was probed with the anti-necdin MNF antibody. Equal loading was
verified by stripping and reprobing the blot with anti-tubulin antibody
(not shown).
Co-immunoprecipitation experiments were then carried out in both COS
and PC12 cells to confirm the p75-necdin and p75-MAGE-H1 interactions.
In accordance with the RRS results, p75 co-precipitated with necdin or
MAGE-H1 from transfected COS cells (Fig.
2A) or PC12 cells (Fig.
2B). In PC12 cell lines stably transfected with necdin,
application of either NGF or BDNF clearly enhanced the interaction of
necdin with p75 (Fig. 2C). Necdin protein levels did not
change during the course of this experiment (data not shown). Finally,
a p75-necdin interaction at endogenous levels of expression was
demonstrated by co-immunoprecipitation from lysates of freshly
dissected adult rat DRG (Fig. 2D).
|
NRAGE was previously found to affect p75-trk association (12), and we therefore examined whether necdin had similar effects in transiently transfected COS cells stimulated with NGF. TrkA co-precipitated together with p75 in the absence of necdin, and this association was lost in necdin-expressing cells (Fig. 2E). Thus, by interacting with p75, necdin can modulate association of p75 with other neurotrophin receptors.
Necdin, like other MAGE family proteins, does not have any known intrinsic catalytic activity and is likely to signal by recruiting other molecules to a p75 signaling complex. We therefore conducted additional RRS screens using necdin as bait and identified a number of novel expressed sequence tags of unknown function as necdin interactors (data not shown). Interestingly, one known gene obtained in this screen was necdin itself (Fig. 2F, left). Homo-oligomerization of necdin was confirmed by co-immunoprecipitation of differentially tagged necdin proteins from transfected COS cells (Fig. 2F, right).
PC12 cells are a well established model for NGF-induced differentiation
and do not express endogenous necdin (14). We therefore examined the
influence of transient transfection of necdin or MAGE-H1 on NGF effects
in PC12 cells. Both necdin- and MAGE-H1-transfected cells responded to
NGF by a dose-dependent increase in neurite extension,
which was greater than observed in vector-transfected cells (Fig.
3A). This accelerated neurite
extension was quantified in stable necdin-PC12 lines (Fig.
3B). Necdin expression levels did not change over the time
course of these experiments (data not shown). No effect was observed on
the number of differentiated cells. Enhanced neurite extension was not
observed when BDNF was applied instead of NGF or upon application of
NGF or BDNF to transfected nnr5 cells (data not shown). To establish
whether the enhanced neurite outgrowth might be a consequence of
accelerated differentiation, we quantified the phosphorylation levels
of cdc2, a cell cycle marker (15). Phosphorylation of cdc2 was
decreased ~5-fold more in necdin-PC12 cells as compared with
vector-PC12 cells 24 h after NGF application (Fig. 3C),
indicating that the effect of the NGF-p75-necdin signal in these cells
is indeed to accelerate differentiation. Finally, we examined the
subcellular distribution of necdin expression in both cycling and
differentiated PC12-necdin cells. As shown in Fig. 3D necdin
protein was primarily cytoplasmic in cycling PC12, and this did not
change upon differentiation. An appreciable amount of necdin was found
in processes and growth cones of differentiated PC12 (Fig.
3D, lower). Microscopy after harsher
permeabilization or Western blot of nuclear extracts revealed lower
amounts of necdin in the nucleus (data not shown). The low levels of
nuclear necdin did not change after NGF stimulation or during
differentiation (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
These results establish two members of the type II MAGE gene family, necdin and MAGE-H1, as p75 interactors. Necdin and MAGE-H1 are related to NRAGE, which was previously identified as a p75 interactor (12). All three interactors contain a conserved sequence called the MAGE homology domain (MHD), a defining feature of the MAGE gene family (5). Since both necdin and MAGE-H1 are essentially comprised of only the MHD, this structural domain determines the interaction of MAGE proteins with p75. Since most type II MAGE proteins are at least as closely related in sequence to MAGE-H1 or necdin or NRAGE as the latter three are to each other (Fig. 1B), additional members of this subfamily may also associate with p75. The death domain of p75 belongs to the structurally distinct type II fold (4), and the possibility that type II MAGE proteins form a family of binding partners for type II death domain proteins is an intriguing avenue for future study. The multiplicity of potential interactions between these two families may create a compensatory network that is physiologically robust, but at the same time refractory to reductionist analysis. For example, the three MAGE interactors for p75 have overlapping expression profiles, which may complicate the analyses of null allelles for these genes, at least in the context of p75 signaling.
We examined the effects of NGF-induced p75 signaling via the two MAGE interactors in PC12 cells and found that they cause an acceleration of neuronal differentiation (Fig. 3). The p75-necdin signal must synergize with a TrkA signaling pathway, since the effects of necdin on differentiation are not seen in nnr5 cells, which lack TrkA, or upon application of BDNF to PC12 cells. Importantly, the effects of necdin on PC12 differentiation were seen only in ligand-stimulated cells and are therefore consequent to NGF signaling. Very recently published data from antisense experiments on embryonic DRG neurons also support a differentiation or survival-promoting role for necdin in NGF-responsive neurons (9). This could be due to a change in trk-p75 association (Fig. 2E), thus "freeing" TrkA from some inhibitory constraint imposed by p75, or could be due to an independent signal emanating from p75 and transduced by necdin. The propensity of necdin for homo-oligomerization (Fig. 2F), and its cytoplasmic localization in PC12 (Fig. 3D), both support the likelihood of necdin acting as a cytoplasmic adaptor for a p75-induced signaling complex. It should, however, be noted that this does not rule out a nuclear localization or role for necdin in other cell types (16).
Although these in vitro analyses suggest a role for a p75-necdin signal in neuronal differentiation, what might be the in vivo significance of such signaling? The most prominent sites of necdin expression in rodents are the DRG and hypothalamus (Fig. 1C), both of which are known to also express p75 and trk receptors. A significant (and unexplained) loss of DRG neurons has been described in p75 null mice (17), and specific hypothalamic defects have been described in one line of necdin mutant mice (18). Comparative analyses of these mutant mice may shed light on this interesting question.
To summarize, we have identified necdin and MAGE-H1 as novel
interactors for the intracellular domain of p75 and suggest that type
II MAGE proteins will feature prominently in p75 signal transduction.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Phil Barker, Moses Chao, and Louis Reichardt for generous gifts of antisera; to Ami Aronheim for gracious help with RRS; and to R'ada Massarwa for excellent technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the Israel Science Foundation (647/01) and the European Union Fifth Framework Program (QLRT-1999-573) (to M. F.) and by a short term European Molecular Biology fellowship (to M. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Incumbent of the Daniel Koshland Sr. Career Development Chair
at the Weizmann Institute of Science. To whom correspondence should be
addressed. Tel.: 972-8-934-4266; Fax: 972-8-934-4112; E-mail:
mike.fainzilber@weizmann.ac.il.
Published, JBC Papers in Press, October 31, 2002, DOI 10.1074/jbc.C200533200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RRS, Ras rescue system; PMSF, phenylmethylsulfonyl fluoride; NGF, nerve growth factor; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; HA, hemagglutinin; PBS, phosphate-buffered saline; DRG, dorsal root ganglia; BDNF, brain-derived neurotrophic factor; MHD, MAGE homology domain.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bentley, C. A.,
and Lee, K. F.
(2000)
J. Neurosci.
20,
7706-7715 |
| 2. | von Schack, D., Casademunt, E., Schweigreiter, R., Meyer, M., Bibel, M., and Dechant, G. (2001) Nat. Neurosci. 4, 977-978[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Hempstead, B. L. (2002) Curr. Opin. Neurobiol. 12, 260-267[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Liepinsh, E., Ilag, L. L., Otting, G., and Ibanez, C. F. (1997) EMBO J. 16, 4999-5005[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Barker, P. A., and Salehi, A. (2002) J. Neurosci. Res. 67, 705-712[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Broder, Y. C., Katz, S., and Aronheim, A. (1998) Curr. Biol. 8, 1121-1124[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Weskamp, G., and Reichardt, L. (1991) Neuron 6, 649-663[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Niinobe, M., Koyama, K., and Yoshikawa, K. (2000) Dev. Neurosci. 22, 310-319[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Takazaki, R., Nishimura, I., and Yoshikawa, K. (2002) Exp. Cell Res. 277, 220-232[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Clary, D. O., Weskamp, G., Austin, L. R., and Reichardt, L. F. (1994) Mol. Biol. Cell 5, 549-563[Abstract] |
| 11. | Maruyama, K., Usami, M., Aizawa, T., and Yoshikawa, K. (1991) Biochem. Biophys. Res. Commun. 178, 291-296[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Salehi, A. H., Roux, P. P., Kubu, C. J., Zeindler, C., Bhakar, A., Tannis, L. L., Verdi, J. M., and Barker, P. A. (2000) Neuron 27, 279-288[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Zhu, F., Yan, W., Zhao, Z. L., Chai, Y. B., Lu, F., Wang, Q., Peng, W. D., Yang, A. G., and Wang, C. J. (2000) BioTechniques 29, 310-313[Medline] [Order article via Infotrieve] |
| 14. | Aizawa, T., Maruyama, K., Kondo, H., and Yoshikawa, K. (1992) Brain Res. Dev. Brain Res. 68, 265-274[Medline] [Order article via Infotrieve] |
| 15. |
Dobashi, Y.,
Shoji, M.,
Kitagawa, M.,
Noguchi, T.,
and Kameya, T.
(2000)
J. Biol. Chem.
275,
12572-12580 |
| 16. | Taniura, H., and Yoshikawa, K. (2002) J. Cell. Biochem. 84, 545-555[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Fan, G., Jaenisch, R., and Kucera, J. (1999) Neuroscience 90, 259-268[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Muscatelli, F.,
Abrous, D. N.,
Massacrier, A.,
Boccaccio, I., Le,
Moal, M.,
Cau, P.,
and Cremer, H.
(2000)
Hum. Mol. Genet.
9,
3101-3110 |
This article has been cited by other articles:
![]() |
J. M. Bischof, C. L. Stewart, and R. Wevrick Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome Hum. Mol. Genet., November 15, 2007; 16(22): 2713 - 2719. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lopez-Sanchez, Z. Gonzalez-Fernandez, M. Niinobe, K. Yoshikawa, and J. M. Frade Single mage gene in the chicken genome encodes CMage, a protein with functional similarities to mammalian type II Mage proteins Physiol Genomics, July 18, 2007; 30(2): 156 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Urra, C. A. Escudero, P. Ramos, F. Lisbona, E. Allende, P. Covarrubias, J. I. Parraguez, N. Zampieri, M. V. Chao, W. Annaert, et al. TrkA Receptor Activation by Nerve Growth Factor Induces Shedding of the p75 Neurotrophin Receptor Followed by Endosomal {gamma}-Secretase-mediated Release of the p75 Intracellular Domain J. Biol. Chem., March 9, 2007; 282(10): 7606 - 7615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurita, T. Kuwajima, I. Nishimura, and K. Yoshikawa Necdin Downregulates Cdc2 Expression to Attenuate Neuronal Apoptosis. J. Neurosci., November 15, 2006; 26(46): 12003 - 12013. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuwajima, I. Nishimura, and K. Yoshikawa Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. J. Neurosci., May 17, 2006; 26(20): 5383 - 5392. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Kuwako, A. Hosokawa, I. Nishimura, T. Uetsuki, M. Yamada, S. Nada, M. Okada, and K. Yoshikawa Disruption of the Paternal Necdin Gene Diminishes TrkA Signaling for Sensory Neuron Survival J. Neurosci., July 27, 2005; 25(30): 7090 - 7099. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Jungbluth, S. Ely, M. DiLiberto, R. Niesvizky, B. Williamson, D. Frosina, Y.-T. Chen, N. Bhardwaj, S. Chen-Kiang, L. J. Old, et al. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation Blood, July 1, 2005; 106(1): 167 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, C. L. Walker, B. Karten, S. L. Kuny, A. A. Tennese, M. A. O'Neill, and R. Wevrick Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth Hum. Mol. Genet., March 1, 2005; 14(5): 627 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuwajima, H. Taniura, I. Nishimura, and K. Yoshikawa Necdin Interacts with the Msx2 Homeodomain Protein via MAGE-D1 to Promote Myogenic Differentiation of C2C12 Cells J. Biol. Chem., September 24, 2004; 279(39): 40484 - 40493. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. da Costa, C. McGillivray, Q. Bai, J. D. Wood, G. Evans, and K.-C. Chang Restriction of Dietary Energy and Protein Induces Molecular Changes in Young Porcine Skeletal Muscles J. Nutr., September 1, 2004; 134(9): 2191 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Laduron, R. Deplus, S. Zhou, O. Kholmanskikh, D. Godelaine, C. De Smet, S. D. Hayward, F. Fuks, T. Boon, and E. De Plaen MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription Nucleic Acids Res., August 17, 2004; 32(14): 4340 - 4350. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gentry, N. J. Rutkoski, T. L. Burke, and B. D. Carter A Functional Interaction between the p75 Neurotrophin Receptor Interacting Factors, TRAF6 and NRIF J. Biol. Chem., April 16, 2004; 279(16): 16646 - 16656. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Albrecht and S. C. Froehner DAMAGE, a Novel {alpha}-Dystrobrevin-associated MAGE Protein in Dystrophin Complexes J. Biol. Chem., February 20, 2004; 279(8): 7014 - 7023. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Kuwako, H. Taniura, and K. Yoshikawa Necdin-related MAGE Proteins Differentially Interact with the E2F1 Transcription Factor and the p75 Neurotrophin Receptor J. Biol. Chem., January 16, 2004; 279(3): 1703 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Garcia, C. S. Lobsiger, S. B. Shah, T. J. Deerinck, J. Crum, D. Young, C. M. Ward, T. O. Crawford, T. Gotow, Y. Uchiyama, et al. NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth J. Cell Biol., December 8, 2003; 163(5): 1011 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Kanning, M. Hudson, P. S. Amieux, J. C. Wiley, M. Bothwell, and L. C. Schecterson Proteolytic Processing of the p75 Neurotrophin Receptor and Two Homologs Generates C-Terminal Fragments with Signaling Capability J. Neurosci., July 2, 2003; 23(13): 5425 - 5436. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Bronfman, M. Tcherpakov, T. M. Jovin, and M. Fainzilber Ligand-Induced Internalization of the p75 Neurotrophin Receptor: A Slow Route to the Signaling Endosome J. Neurosci., April 15, 2003; 23(8): 3209 - 3220. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |